January 14, 2019  WOBURN, Mass.–(BUSINESS WIRE)–OSSIO, an orthopedic fixation company, today announced that its OSSIOfiber™ BonePin Family has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). This first of its kind technology features a proprietary bio-integrative material to provide stability and secure bone fixation during the healing process, leaving no permanent …